The bactericidal activity of DR-3355, an optically active isomer of ofloxacin
- 1 November 1989
- journal article
- research article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 30 (3) , 227-231
- https://doi.org/10.1099/00222615-30-3-227
Abstract
The bactericidal activity of compound DR-3355, an optically active isomer of ofloxacin, was measured against Escherichia coli, Staphylococcus aureus and S. epidermidis, in nutrient broth and in phosphate-buffered saline. DR-3355 was found to be approximately twice as active as ofloxacin in terms of the concentration at which maximum bacterial kill was achieved. Hence it appears that DR-3355 is twice as active as ofloxacin not only in terms of its ability to inhibit bacterial multiplication but also in its ability to kill bacteria. DR-3355 was found to be active against non-dividing bacteria and did not require either active RNA or protein biosynthesis in order to kill bacteria.This publication has 6 references indexed in Scilit:
- In vitro activity of DR-3355, an optically active ofloxacinAntimicrobial Agents and Chemotherapy, 1988
- Trimethoprim resistance determinants encoding a dihydrofolate reductase in clinical isolates of Staphylococcus aureus and coagulase-negative staphylococciJournal of Medical Microbiology, 1988
- In vitro studies of S-25930 and S-25932, two new 4-quinolonesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactionsAntimicrobial Agents and Chemotherapy, 1985
- The pharmacokinetics and tissue penetration of ofloxacinJournal of Antimicrobial Chemotherapy, 1984
- Mechanism of Action of Nalidixic Acid on Escherichia coli III. Conditions Required for LethalityJournal of Bacteriology, 1966